Intended for healthcare professionals

CCBYNC Open access

“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study

BMJ 2019; 367 doi: (Published 12 December 2019) Cite this as: BMJ 2019;367:l6694

Commercial influence in health: from transparency to independence

Click here to read the complete collection

Linked Opinion

I’m more susceptible to drug company money than I’d like to be